Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 15 March 2023
Adhoc Press Release
Kuros Biosciences reports results for the full year 2022
Kuros Annual Report, 2022
English version
Press Release, 21 February 2023
Kuros Biosciences Announces Publication of Supportive Osteoimmunology Data for MagnetOs Bone Graft
Press Release, 16 February 2023
Adhoc Press Release
Kuros Biosciences Announces Changes to Executive Management Team
Press Release, 23 November 2022
Kuros Biosciences Completes Enrollment of Randomized Stage of Phase 2 Trial for Fibrin-PTH
Press Release, 2 November 2022
Kuros Biosciences completes enrolment in Level 1 clinical study of MagnetOs Granules